Platelet aggregation induced by serotype polysaccharides from Streptococcus mutans.
Platelet aggregation plays an important role in the pathogenesis of infective endocarditis induced by viridans streptococci or staphylococci. Aggregation induced in vitro involves direct binding of bacteria to platelets through multiple surface components. Using platelet aggregometry, we demonstrated in this study that two Streptococcus mutans laboratory strains, GS-5 and Xc, and two clinical isolates could aggregate platelets in an irreversible manner in rabbit platelet-rich plasma preparations. The aggregation was partially inhibited by prostaglandin I(2) (PGI(2)) in a dose-dependent manner. Whole bacteria and heated bacterial cell wall extracts were able to induce aggregation. Cell wall polysaccharides extracted from the wild-type Xc strain, containing serotype-specific polysaccharides which are composed of rhamnose-glucose polymers (RGPs), could induce platelet aggregation in the presence of plasma. Aggregation induced by the serotype-specific RGP-deficient mutant Xc24R was reduced by 50% compared to the wild-type strain Xc. In addition, cell wall polysaccharides extracted from Xc24R failed to induce platelet aggregation. The Xc strain, but not the Xc24R mutant, could induce platelet aggregation when preincubated with plasma. Both Xc and Xc24R failed to induce platelets to aggregate in plasma depleted of immunoglobulin G (IgG), but aggregation was restored by replenishment of anti-serotype c IgG. Analysis by flow cytometry showed that S. mutans RGPs could bind directly to rabbit and human platelets. Furthermore, cell wall polysaccharides extracted from the Xc, but not the Xc24R, strain could induce pseudopod formation of both rabbit and human platelets in the absence of plasma. Distinct from the aggregation of rabbit platelets, bacterium-triggered aggregation of human platelets required a prolonged lag phase and could be blocked completely by PGI(2). RGPs also trigger aggregation of human platelets in a donor-dependent manner, either as a transient and reversible or a complete and irreversible response. These results indicated that serotype-specific RGPs, a soluble product of S. mutans, could directly bind to and activate platelets from both rabbit and human. In the presence of plasma containing IgG specific to RGPs, RGPs could trigger aggregation of both human and rabbit platelets, but the degree of aggregation in human platelets depends on the donors.
Chia
Jean-San
JS
Department of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan, Republic of China. chiajs@ha.mc.ntu.edu.tw
Lin
Ya-Lin
YL
Lien
Huei-Ting
HT
Chen
Jen-Yang
JY
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects / Q000473:pathology; D048429:Cell Size / Q000187:drug effects; D004697:Endocarditis, Bacterial / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects*; D011135:Polysaccharides, Bacterial / Q000737:chemistry / Q000276:immunology / Q000633:toxicity*; D011817:Rabbits; D012703:Serotyping; D013290:Streptococcal Infections / Q000209:etiology; D013295:Streptococcus mutans / Q000145:classification / Q000276:immunology / Q000472:pathogenicity*
D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D011135:Polysaccharides, Bacterial